Arkadios Wealth Advisors Citius Pharmaceuticals, Inc. Transaction History
Arkadios Wealth Advisors
- $1.23 Billion
- Q1 2024
A detailed history of Arkadios Wealth Advisors transactions in Citius Pharmaceuticals, Inc. stock. As of the latest transaction made, Arkadios Wealth Advisors holds 100,000 shares of CTXR stock, worth $53,000. This represents 0.01% of its overall portfolio holdings.
Number of Shares
100,000
Previous 100,000
-0.0%
Holding current value
$53,000
Previous $76,000
18.42%
% of portfolio
0.01%
Previous 0.01%
Shares
1 transactions
Others Institutions Holding CTXR
# of Institutions
73Shares Held
26.8MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY8.73MShares$4.63 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.01MShares$3.71 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.95MShares$1.56 Million0.0% of portfolio
-
State Street Corp Boston, MA2.21MShares$1.17 Million0.0% of portfolio
-
Northern Trust Corp Chicago, IL1.12MShares$593,7530.0% of portfolio
About Citius Pharmaceuticals, Inc.
- Ticker CTXR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 146,130,000
- Market Cap $77.4M
- Description
- Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of critical care products focusing on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. The company is developing five proprietary products comprising Mino-Lok, an antibiotic l...